GEN Exclusives

More »

GEN News Highlights

More »
Feb 6, 2008

Vermillion and Johns Hopkins Continue on Quest to Develop Cancer Diagnostics

  • Vermillion renewed a long-standing collaboration with Johns Hopkins University for the development of novel cancer biomarkers. Vermillion will have exclusive access to commercial rights related to the discoveries made through the partnership.

    The collaborators expect to apply them to disease detection, classification, and monitoring of cancers including ovarian, breast, and prostate.

    Vermillion will continue to provide financial support, technical assistance, and access to its technologies. Johns Hopkins will contribute cancer serum samples and the clinical and scientific expertise.

    “For more than seven years we have had a highly productive relationship with Daniel W. Chan, professor of pathology/urology/oncology/radiology and his esteemed team at Johns Hopkins University,” points out Eric Fung, M.D., Ph.D., CSO of Vermillion. “This collaboration has led to the development of our ovarian tumor triage test, and we look forward to expanding this steadfast relationship.”



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Lab-Grown Vaginas

Which body part do you think will be successfully engineered in the lab next?